Two Pot Companies Continue To Focus On Cannabinoid-Based Self-Emulsifying Drug Delivery Systems
Portfolio Pulse from Vuk Zdinjak
Avicanna Inc. (AVCNF) extends its strategic manufacturing agreement with Medipharm Labs Inc. (MEDIF) for the commercialization of Avicanna's proprietary cannabinoid-based self-emulsifying drug delivery systems (SEDDS) technology capsules in Canadian and international markets. The capsules will be commercialized under the RHO Phyto brand and MediPharm Labs brand.
June 26, 2023 | 1:37 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Avicanna extends its strategic manufacturing agreement with Medipharm Labs for the commercialization of its proprietary cannabinoid-based SEDDS technology capsules.
The extended agreement with Medipharm Labs will allow Avicanna to commercialize its proprietary SEDDS technology capsules in Canadian and international markets, potentially increasing its revenue and market presence.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Medipharm Labs extends its strategic manufacturing agreement with Avicanna for the commercialization of Avicanna's proprietary cannabinoid-based SEDDS technology capsules.
The extended agreement with Avicanna will allow Medipharm Labs to manufacture and commercialize the proprietary SEDDS technology capsules in Canadian and international markets, potentially increasing its revenue and market presence.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100